"Alprostadil" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A potent vasodilator agent that increases peripheral blood flow.
| Descriptor ID |
D000527
|
| MeSH Number(s) |
D10.251.355.255.550.250.100 D10.251.355.325.050 D23.469.050.175.725.250.100
|
| Concept/Terms |
Alprostadil- Alprostadil
- PGE1alpha
- Prostaglandin E1alpha
- PGE1
- Lipo-PGE1
- Lipo PGE1
- Prostaglandin E1
|
Below are MeSH descriptors whose meaning is more general than "Alprostadil".
Below are MeSH descriptors whose meaning is more specific than "Alprostadil".
This graph shows the total number of publications written about "Alprostadil" by people in this website by year, and whether "Alprostadil" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 2 | 2 |
| 1997 | 2 | 0 | 2 |
| 1998 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
| 2018 | 1 | 0 | 1 |
| 2020 | 0 | 1 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Alprostadil" by people in Profiles.
-
Saraiya A, Yu J, Huang C, Frisch D, Pavri BB. Evaluating Goldberger's triad as a marker of congestive heart failure: A systematic review and retrospective study. J Electrocardiol. 2023 Nov-Dec; 81:207-213.
-
Vari D, Xiao W, Behere S, Spurrier E, Tsuda T, Baffa JM. Low-dose prostaglandin E1 is safe and effective for critical congenital heart disease: is it time to revisit the dosing guidelines? Cardiol Young. 2021 Jan; 31(1):63-70.
-
Morra I, Ferrara C, Sglavo G, Sansone A, Saccone G, Perriera L, Di Carlo C. Incidence of uterine rupture in second-trimester abortion with gemeprost alone compared to mifepristone and gemeprost. Contraception. 2019 03; 99(3):152-154.
-
Arya D, Chang S, DiMuzio P, Carpenter J, Tulenko TN. Sphingosine-1-phosphate promotes the differentiation of adipose-derived stem cells into endothelial nitric oxide synthase (eNOS) expressing endothelial-like cells. J Biomed Sci. 2014 Jun 04; 21:55.
-
Christie JD, Bavaria JE, Palevsky HI, Litzky L, Blumenthal NP, Kaiser LR, Kotloff RM. Primary graft failure following lung transplantation. Chest. 1998 Jul; 114(1):51-60.
-
Davidson SM, Cabral-Lilly D, Maurio FP, Franklin JC, Minchey SR, Ahl PL, Janoff AS. Association and release of prostaglandin E1 from liposomes. Biochim Biophys Acta. 1997 Jul 05; 1327(1):97-106.
-
Ismail M, Abbott L, Hirsch IH. Experience with intracavernous PGE-1 in the treatment of erectile dysfunction: dose considerations and efficacy. Int J Impot Res. 1997 Mar; 9(1):39-42.
-
Watanabe T, Chancellor MB, Rivas DA, Hirsch IH, Bennett CJ, Finocchiaro MV, Razi S, Bennett JK, Green BG, Foote JE, Killorian RW, Juma S, Linsenmeyer TA, Lloyd K. Epidemiology of current treatment for sexual dysfunction in spinal cord injured men in the USA model spinal cord injury centers. J Spinal Cord Med. 1996 Jul; 19(3):186-9.
-
Gomella LG. Impotence--defining the role of minimally invasive therapy. J Urol. 1996 Jan; 155(1):147.
-
Smalling RW, Feld S, Ramanna N, Amirian J, Felli P, Vaughn WK, Swenson C, Janoff A. Infarct salvage with liposomal prostaglandin E1 administered by intravenous bolus immediately before reperfusion in a canine infarction-reperfusion model. Circulation. 1995 Aug 15; 92(4):935-43.